Showing results (1421-1430 of 1,447) with videos related to
Sort By:
Pageof 145
The New England Journal of Medicine|July 14, 2016
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast CancerHope S Rugo, Olufunmilayo I Olopade, Angela DeMichele, et al.Neurology|May 30, 2008
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD StudyJ E Tobin, J C Latourelle, M F Lew, et al.Plos One|April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trialPatricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.Nature Genetics|July 28, 2014
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseMike A Nalls, Nathan Pankratz, Christina M Lill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 TrialA Jo Chien, Debasish Tripathy, Kathy S Albain, et al.Annals of Clinical and Translational Neurology|June 19, 2025
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome SequencingMirja Thomsen, Fabian Ott, Sebastian Loens, et al.BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2020
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer CareNathan A Pennell, Melissa Dillmon, Laura A Levit, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2023
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker DiscoveryKathy S Albain, Christina Yau, Emanuel F Petricoin, et al.The New England Journal of Medicine|July 15, 2026
Health Care-Associated Infections in U.S. Hospitals, 2023 versus 2015Nora Chea, Rongxia Li, Taniece Eure, et al.Pageof 145